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Abstract
With its inclusion under Action 3 in the Environment and Health Action Plan 2004–2010 of the
European Commission, human biomonitoring is currently receiving an increasing amount of
attention from the scientific community as a tool to better quantify human exposure to, and health
effects of, environmental stressors. Despite the policy support, however, there are still several
issues that restrict the routine application of human biomonitoring data in environmental health
impact assessment. One of the main issues is the obvious need to routinely collect human samples
for large-scale surveys. Particularly the collection of invasive samples from susceptible populations
may suffer from ethical and practical limitations. Children, pregnant women, elderly, or chronically-
ill people are among those that would benefit the most from non-invasive, repeated or routine
sampling. Therefore, the use of non-invasively collected matrices for human biomonitoring should
be promoted as an ethically appropriate, cost-efficient and toxicologically relevant alternative for
many biomarkers that are currently determined in invasively collected matrices. This review
illustrates that several non-invasively collected matrices are widely used that can be an valuable
addition to, or alternative for, invasively collected matrices such as peripheral blood sampling.
Moreover, a well-informed choice of matrix can provide an added value for human biomonitoring,
as different non-invasively collected matrices can offer opportunities to study additional aspects of
exposure to and effects from environmental contaminants, such as repeated sampling, historical
overview of exposure, mother-child transfer of substances, or monitoring of substances with short
biological half-lives.
Background
The recent adoption of human biomonitoring (HBM) as
Action 3 in the Environment and Health Action Plan
2004–2010 of the European Commission [1,2] has moti-
vated the implementation and application of HBM in
European environment and health research.
One of the most important issues hampering the routine
application of HBM on a large scale is the obvious need to
collect human samples, often invasively. Blood has the
undeniable advantage that it is in contact with all tissues
and in equilibrium with organs and tissues. Therefore, it
has been used extensively for various research and survey
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goals. However, blood sampling is an invasive procedure
and suffers from ethical and practical constraints, particu-
larly for small children or other susceptible populations
[3,4]. The European Commission's SCALE Initiative (Sci-
ence, Children, Awareness, EU Legislation and continu-
ous Evaluation) has specifically identified children as a
main target population for environment and health poli-
cies, so including this subpopulation in any HBM project
is a priority [5]. Likewise, sampling non-invasively col-
lected matrices is preferable in particularly vulnerable
groups, such as pregnant women, elderly, or chronically-
ill people.
Additionally, repeated or even routine biomonitoring
may be desirable for the efficiency evaluation of risk man-
agement options and efficacy of environment and health
policies. For short-lived chemicals such as volatile organic
compounds or agricultural pesticides, average exposures
may not reflect peak exposures arising through infrequent
exposure episodes. Repeated sampling of high-exposure
subjects provides more insight into the true nature of
these episodes and of their toxicological consequences
[6,7].
Finally, because non-invasively collected matrices need
less specialized personnel for sampling, costs associated
with large sampling designs may be significantly reduced
[8,9].
Because of these advantages, there is a strong case for non-
invasively collected matrices for human biomonitoring as
an ethically appropriate, cost-efficient and toxicologically
relevant alternative for many of the biomarkers currently
determined in invasive matrices. Moreover, a well-
informed choice of matrix can provide an added value for
HBM, as different non-invasively collected matrices offer
opportunities to study additional aspects of exposure to
and effects from environmental contaminants, such as
short- and long-term toxicokinetics, changing exposure
over time, or monitoring of volatile chemicals or sub-
stances with short half-lives (Figure 1) [4].
An overview of non-invasively collected matrices
It has been shown extensively that even the unborn child
may already prenatally come in contact with hazardous
substances [4,10]. While the placenta is the obvious
choice to study this exposure pathway, it can also act as a
barrier for toxicants and thereby to some extend reduce
exposure of the foetus [11,12]. Using placenta and/or
cord blood as a matrix for biomonitoring offers the
advantage that at the same time, the exposure history of
both the mother and the early exposure of the newborn
infant is studied. A downside of using the placenta as a
biomonitoring matrix, is that it may be difficult to collect
representative samples. It is a complex mixture of blood
vessels, chorionic villi and membranes, and metals for
example are not uniformly distributed [12,13]. Cord
blood has the additional advantage that several well-
defined and documented standard operation procedures
(SOPs) for peripheral blood can be applied. However, the
volume of cord blood samples is usually limited and col-
lection suffers from the major disadvantage that it is not
always practically feasible to collect repeated representa-
tive samples [14]. The main care during delivery goes to
the well-being of mother and child, and collecting cord
blood samples may not always be practically feasible.
Also after birth, newborns may take up chemicals through
specific pathways that offer great potential as non-inva-
sively collected matrices for biomonitoring. Human milk
is considered one of the most acceptable matrices for
monitoring persistent bio-accumulating toxicants (PBTs).
In the lactation period, human milk is a major uptake
route for environmental contaminants due to its fatty
character, especially for primigravidae mothers [15,16].
Human milk is easy to collect, enriched in lipophylic
compounds and represents the main exposure source for
breast feeding infants [17]. One of the major disadvantage
of using placenta, cord blood or human milk as a non-
invasively collected matrix for biomonitoring is that only
women and their children can be included in a biomoni-
toring study, and only at certain periods in their lives [3].
Urine is probably the most frequently used matrix in
humans to quantify the degree of environmental or occu-
Some properties of different non-invasively collected matri- ces for routine human biomonitoring application Figure 1
Some properties of different non-invasively collected 
matrices for routine human biomonitoring applica-
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pational exposure to pollutants, especially for substances
with short biological half-lives [3,18]. The collection and
analysis of urine samples carries no associated risk, and
large volumes can at once be gathered per individual [19].
Spot collection of samples is most frequently used in bio-
monitoring programmes, especially for surveys where
large numbers of samples need to be gathered. The major
disadvantage of using spot samples is the variability in the
volume and concentration of urine. Hence, spot urine
samples are standardised based on two different methods:
￿ By expression per gram of creatinine [19,20]. The World
Health Organisation (WHO) has developed guidelines
which stipulate that samples with creatinine concentra-
tions <30 or >300 mg/dL are regarded as either too diluted
or too concentrated [21]. However, these guidelines have
been questioned recently based on detailed assessment of
the role of age, gender and ethnicity and may not be
appropriate for pregnant women or children [18];
￿ Another commonly used method to standardise
biomarker measurements in urine is to take account of the
gravity or relative density of urine [19].
Probably the major advantage of urine as a non-invasively
collected matrix is the ease with which repeated sampling
can be performed without major ethical or practical limi-
tations across all layers of the population, including
babies, young children and other susceptible populations.
The advantage of repeated sampling is also valid when
using hair as a non-invasively collected matrix. Hair has
been successfully used to measure both internal and exter-
nal exposure to a wide variety of organic and inorganic
pollutants [22-24]. As hair grows about one centimetre
per month, analysis of hair of different length may reflect
cumulative exposure over several months. Taking advan-
tage of this property of hair, differences in exposure over
several months or even years can be followed. Potential
constraints on the use of hair include the difficulty in dif-
ferentiating between internal and external sources of con-
taminant and the widespread use of hair treatment
products [25,26]. Also, repeated hair sampling is not
always well-received for esthetical reasons, as this may
impact hair style. Remarkably, also home-collection of
urine samples may face some resistance, as some age
groups are reluctant to walk around with their urine sam-
ples (E. den Hond, personal communication).
Using exhaled breath as a non-invasively collected matrix
offers the potential to directly relate substances in ambi-
ent air to exhaled concentrations of biological and toxico-
logical relevance. Measuring exposure and effect
biomarkers in exhaled air may be highly suitable for the
characterization of dose at the target organ level, in this
case the lungs and respiratory system [27,28]. Because for
most collection systems only tidal breathing is needed,
the samples can be collected in a broad range of subjects.
Samples can also be collected from very young children or
individuals with airway diseases.
Also other matrices, such as meconium, finger/toenails or
saliva offer great potential for routine application in
human biomonitoring. Although their use and applicabil-
ity is much less documented in literature than the ones
previously discussed, some examples and potential future
applications are given below.
Troublesome sample collection and level of invasiveness
are commonly cited reasons why study participants do
not want to provide biospecimens for research purposes
[9]. Using non-invasively collected matrices, possibly
gathered through home-collection, may dramatically
improve participation rates of populations because less
effort is involved for the participants [29,30] or because it
lowers the guardians' objections for children's participa-
tion [31]. Improving the participation rates may have the
added benefit that there is much less selection bias as a
larger subsection of the general population will partici-
pate [32].
Biomarkers of exposure
The application of different non-invasively collected
matrices for the detection and quantification of environ-
mental exposure to metals has abundantly been described
in literature. Iyengar and Rapp illustrate how the placenta
can be used to detect the presence of toxic trace elements
such as arsenic, mercury or lead [13,33-35]. Others addi-
tionally provide data indicating that concentrations of
trace elements can vary 5- to 10-fold due to specific expo-
sure situations, such as living in the vicinity of coal and
metal mining and smelting operations [36]. Also urine,
finger/toenails, or human milk have repeatedly been used
as suitable matrices of exposure for metals. [37-41]. Prob-
ably the best-known use of hair as a non-invasive matrix
for metals is in the biomonitoring of organic and inor-
ganic mercury, as hair is by far the best integrator of past
exposure [42,43], although also other metals have repeat-
edly been monitored using hair [44-46].
Also for organic compounds, several non-invasively col-
lected matrices have frequently been used to quantify
chemicals that are lipophylic and resistant to metabolic
degradation. Many persistent environmental pollutants,
such as polychlorinated dibenzo-p-dioxins (PCDDs) and
dibenzofurans (PCDFs) are widespread and can be found
in placenta, cord blood, or human milk [47-53]. Meco-
nium has been promoted as a very useful non-invasively
collected matrix to describe exposure of the unborn child
to pesticides or metals [54,55].Environmental Health 2009, 8:8 http://www.ehjournal.net/content/8/1/8
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Urine has frequently been used as a matrix for a wide vari-
ety of both organic and inorganic compounds for occupa-
tional as well as environmental exposure [19,56,57]. As
urine is a main excretory pathway, it is a preferred matrix
to monitor for non-bioaccumulating and rapidly metabo-
lised compounds. Interpretation of urinary biomarkers is
sometimes complicated as they primarily focus on quan-
tification of metabolites rather than the parent com-
pounds. Some chemicals, like chlorpyrifos, are broken
down in the body into a number of metabolites which can
be detected in urine. As these same metabolites also occur
as natural products of environmental degradation, it is
not always possible to distinguish exposure to the parent
compound from exposure to its environmental degra-
dates [3,14].
The gaseous fraction of exhaled breath can be a good bio-
monitor for a wide variety of volatile substances [58,59].
The monitoring of metals in exhaled breath is less well
documented, although Mutti et al [60] show that toxic
metals and transition elements are detectable in exhaled
breath condensate (EBC). This may have potential in the
assessment of the target tissue dose for substances with
potential pneumotoxic activity, such as Cd, Co or Ni
[28,60]. A disadvantage of measuring biomarkers of expo-
sure in the gaseous phase of exhaled air is that the resi-
dence time of substances are generally rather short, in the
order of minutes or hours [58].
When using hair and finger/toenails to quantify exposure
to environmental contaminants, caution is needed in the
interpretation of exposure data. Many contaminants have
been proven to reach hair and finger/toenails via two
major routes: endogenous (xenobiotics reach the hair
matrix through blood) and exogenous (atmospheric dep-
osition) [3,23]. Hence it may be difficult to distinguish
between contaminants taken up and those related to
external contamination. Findings by Nakao et al [61] and
Stupar et al [62] show that hair can in fact be used for the
quantification of exogenous atmospheric exposure and in
some cases even for the estimation of corresponding air
concentrations. Mainly for substances where environmen-
tal exposure does not generally occur through air, the con-
straint of external contamination is limited. For
methylmercury for example, which is generally taken up
through food or dental amalgam, hair is by far the pre-
ferred matrix for biomonitoring and large-scale biomoni-
toring campaigns have clearly linked methylmercury with
neurodevelopmental deficiencies [42]. While washing
procedures have been shown to differentiate between
endogenous and exogenous exposure, caution remains
necessary in the interpretation of using hair as a non-inva-
sively collected matrix for exposure [63].
Tables 1 and 2 provide an overview of typical concentra-
tions of both metals and organic contaminants detected
in different non-invasively collected matrices.
Biomarkers of effect
Detecting the early hazardous effects of environmental
contaminants has a high priority in the protection of
neonates and newborn children [4]. In both placental tis-
sue and cord blood, biomarkers for DNA damage have
been measured using different methods, including 32P-
postlabeling and enzyme-linked immunosorbent assay
(ELISA) methods [64,65]. Although the estimated polycy-
clic aromatic hydrocarbon (PAH) dose to the foetus may
be 10-fold lower than in the mothers because of the earlier
Table 1: An overview of typical concentrations of toxic trace metals reported in non-invasive human matrices (arithmetic mean 
(rangea))
As Cd Hg (total) Pb
Urine
(μg/l)
6.4 (ND-157)
[37]
0.34 (ND-31.5)
[37]
0.89 (ND – 34.8)
[37]
1.3 (0.1–4.6)b
0.8 (0.02–4.8)c
[38]
Urine
(μg/g creatinine)
4.9 (ND-163)
[37]
0.27 (ND-22.4)
[37]
0.59 (ND-16.0)
[37]
0.8d (0.2–3.4)b
0.5d (0.1–4.6)c
[38]
Placenta
(ng/g wet weight)
6 (3–12)
[13]
4 (1–6)
[13]
8 (2–13)
[13]
34 (5–60)
[13]
Cord blood
(μg/l)
15.7 (2.9–74.6)
[33]
0.02 (ND-0.08)
[34]
10 (ND-75)
[35]
11.2 (0.9 – 122)
[34]
Exhaled breath (μg/l) - - (ND-1.70)
[60]
--  ( N D - 1 . 4 )
[60]
Breast milk
(μg/l)
0.3 (0.1–0.8)
[41]
0.1 (0.1–3.8)
[41]
2.7 (0.64–257.1)
[41]
5 (ND-41.1)
[41]
Hair
(μg/g)
0.65 (0.2–8.2)
[44]
0.08 (ND-8.19)
[45]
0.2 (0.04–1.73)e
[46]
2.26 (ND-583.5)
[45]
a Range may include high levels at which adverse effects are expected; b Data for children; c Data for adults; d Geometric mean; e Mean (P10-P95); f 
ND: below detection limitEnvironmental Health 2009, 8:8 http://www.ehjournal.net/content/8/1/8
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mentioned barrier effect of the placenta, the PAH adduct
levels in the newborns are similar or higher than those in
their mothers [66]. This may imply that the foetus is far
more susceptible to DNA damage than its mother [67].
Maervoet et al [68] outlined that, while there are still
many gaps in the understanding of the relationship
between environmental contaminants in cord blood and
the functioning of the thyroid system, any interference
may adversely affect neonatal neurodevelopment. The
discovery that placental nucleic acids can be used as a
marker for prenatal screening has recently opened the
door for the application of rapidly developing technolo-
gies such as toxicogenomics and proteomics. This in the
future may lead to the development of molecular markers
for non-invasive prenatal gene expression profiling of the
foetus using placenta and cord blood [69].
Also for other non-invasively collected matrices, the use of
relatively new '-omics' technologies has opened the door
for the detection of new biomarkers of effect. Recently,
there has been increased research interest in the metabolic
profiling (metabonomics or metabolomics) of mainly
urine and exhaled breath samples. This technique encom-
passes the systematic profiling of metabolite concentra-
tions and their systematic and temporal changes through
effects from diet, lifestyle, environment and genetic
[70,71]. Although metabonomics currently is not yet suf-
ficiently developed for large-scale biomonitoring studies,
it may be a promising tool for the rapid screening of
metabolites [71,72].
Other non-invasively collected matrices already have a
long-standing and well-documented history as a matrix in
routine, often clinical, health assessment [73]. For exam-
ple, α1- and β2-microglobulin excretion and retinol-bind-
ing proteins in urine have frequently been described as
sensitive biomarkers of renal disfunctioning [74]. Addi-
tionally, urine has been used as a non-invasive matrix for
the quantification of base DNA-adducts as biomarkers for
carcinogenesis [75]. Urinary 8-hydroxy-deoxyguanosine
(8-OHdG) has been used as a biomarker of the DNA
repair response to oxidative stress and DNA-damaging
compounds [14]. Exhaled breath has received much
attention as a suitable clinical matrix for the early detec-
tion of pulmonary and respiratory diseases. It has exten-
sively been demonstrated that fractional exhaled nitric
oxide (FeNO) concentrations in exhaled air are higher in
people suffering from various pulmonary diseases,
including asthma and chronic obstructive pulmonary dis-
ease (COPD) [76,77]. Other biomarkers, such as exhaled
breath temperature, pH of EBC, and the presence of
cytokines (e.g. interleukins (IL) IL-4, IL-6, IL-8 and tumor-
necrosis factor α (TNF-α)), 8-isoprostane or hydrogen
peroxide may also be biomarkers of lung inflammation
and oxidative stress [76,78]. Saliva as a non-invasively col-
lected matrix has been used to quantify cholinesterase
activity, a biomarker for potential neurotoxic effects
[79,80]. Additionally, saliva specimens have been used in
combination with the Ames test or a Chinese hamster V79
lung fibroblast cell line to investigate the genotoxic effects
of smoking and alcohol consumption. exfoliated buccal
cells have been used to monitor genetic damage in
humans using the micronucleus test [81,82].
For other non-invasively collected matrices, such as hair,
human milk, finger/toenails or meconium, we found no
examples of biomarkers of effect.
Table 2: An overview of typical concentrations of toxic organic compounds reported in non-invasive human matrices (arithmetic mean 
(rangea))
Hexachlorobenzene (HCB)
(ng/g lipid)
PCDD/F
(in pg TEQ/g lipid)
Cotinine
(in non-smokers)
Urine
(μg/l)
PCP: 3.8 (0.6–18.0)c
PCBT: 8.8 (0.5–86.9)c
[57]
- 17.9 (ND-3400)
[37]
Urine
(μg/g creatinine)
- - 17.1 (ND-5810)
[37]
Placenta
(ng/g wet weight)
7.7b (2.2–26.5)
[49]
31 (10–74)
[47]
-
Cord blood
(μg/l)
0.73 (0.14–9.82)
[50]
14 (3.7–32)
[47]
3.08 (ND-910)
[51]
Exhaled breath (μg/l) - - 21 (ND-42)e
[59]
Breast milk
(ng/g lipid)
12.4 (6.01–24.56)
[49]
9.5 (2.7–51.5)
[52]
0.2 (0.03–1.3)
[53]
Hair
(μg/g)
28 (20–32)d
[89]
- (0.25–230)
[26]
0.29 (ND-11)
[45]
a Range may include high levels at which adverse effects are expected; b Arithmetic mean (P10-P95); c Metabolites of HCB, expressed in μg/24 h; d 
Median (P25-P75); e Cotinine in saliva; f ND: below detection limitEnvironmental Health 2009, 8:8 http://www.ehjournal.net/content/8/1/8
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Correlations among (non-invasive collected) 
biomonitoring matrices
Many publications have measured and compared values
for biomarkers of exposure for the same chemicals in dif-
ferent (non-invasively collected) matrices. Often, there
are good correlations among invasively collected and
non-invasively collected matrices, although several excep-
tions can be noticed [3].
In several cases, meconium has been shown to be the
most sensitive matrix to analyse fetal exposure to environ-
mental contaminants. For example in mercury or pesti-
cides monitoring, meconium showed the highest
exposure rates compared to cord blood and infant hair
[54,83]. For phthalate metabolites, urinary concentra-
tions have been found to be more informative than blood,
serum or milk concentrations is the Swedish population.
Urinary concentrations showed lower day-to-day variabil-
ity and were detected at much higher concentrations than
in other matrices [84]. For other contaminants, good cor-
relations are often found between paired cord blood or
placenta samples and other matrices such as maternal
blood, human milk or amniotic fluid [85,86].
Urinary biomarkers generally reflect metabolites of com-
pounds rather than the pure compound itself. This makes
it more difficult to correlate urinary biomarkers with
biomarkers of exposure in other matrices. Mainly for non-
metabolised compounds, correlations between concen-
trations in urine and other matrices such as blood appear
to be good [87]. Many authors also have addressed the
correlation between contaminants in hair and other
matrices [88,89]. For inorganic compounds, Mehra and
Juneja [90] reported significant correlations between hair
and fingernail concentrations of Cd and Pb, Stupar et al
[62] found significant correlations between Pb in hair and
blood, and Ng et al [91] reported significant correlations
between hair mercury and mercury in blood, 24 h urine or
cord blood samples following a meta-analysis of mercury
biomonitoring studies.
Compared to invasively collected matrices such as periph-
eral blood, there are very little, if any, chemicals that can-
not be determined with sufficient sensitivity in non-
invasively collected matrices. Concentration of chemicals
in non-invasively collected matrices generally correlates
very well with other, often invasively collected, matrices
such as peripheral blood.
Validation status
Validation of biomarkers is a lengthy and difficult process,
that requires the fulfilment of multiple criteria. In general,
these criteria include understanding the biological and
temporal relevance, pharmacokinetics, background varia-
bility, exposure-dose or dose-response relationship and
identification of confounding factors [92].
Several urinary biomarkers have been fully validated for
organic and inorganic substances, reference materials and
internationally recognised standard methodologies are
often available, and sampling procedures are well-docu-
mented. It is a widely-employed non-invasively collected
matrix in many of the largest environmental studies such
as the German Environmental Survey for children (GerES)
[93], the American National Health and Nutrition Exami-
nation study (NHANES) [18], or the Flemish Human Bio-
monitoring programme [94]. Also human milk as a
matrix has widespread use for biomarkers of exposure. It
is easily collectable and fully validated for a wide variety
of substances and reference materials. Internationally rec-
ognised standards for analysis are often available, and
sampling procedures are well documented. The WHO
coordinates a regular exposure study to using human milk
to quantify the global presence and distribution of persist-
ent organic pollutants. Within the context of this repeated
human biomonitoring program, guidelines for develop-
ing a national protocol for sampling human milk have
been developed [95,96]. Methods of collecting and sam-
pling exhaled breath biomarkers include Tedlar bags, can-
isters, or even portable real-time detectors. These methods
are generally well validated and documented, as are the
measurement techniques [97]. Both the European Respi-
ratory Society (ERS) and American Thoracic Society (ATS)
have developed recommendations the collection and
measurements in EBC and for measuring FeNO [76,77].
Because of the frequent application of meconium for
illicit drug screening, structured screening protocols have
also been developed for this non-invasively collected
matrix [98,99].
A review by the Agency for Toxic Substances and Disease
Registry highlighted some of the shortcomings of hair as a
non-invasive biomonitoring matrix [25]. Although the
review recognised that hair is a very useful matrix for iden-
tifying historical exposure to contaminants and may have
predictive value towards health effects, a large amount of
uncertainty remains regarding sampling procedures, qual-
ity assessment and control issues, and the lack of reference
ranges and dose-response outcomes. Among others, hair
colour and the use of hair treatment products may have a
significant impact on the concentration and availability of
chemicals [25,26]. Other matrices are often used in a
research setting rather than a routine survey setting. While
there may not be internationally accepted standard oper-
ation procedures available, confounding factors for sev-
eral less frequently studied matrices are known. Slotnick
et al [39] evaluated the effect of demographic characteris-
tics and nutritional measures on the association between
drinking water and toenail arsenic concentrations. Apart
from toenail iron concentration, no demographic or
nutritional parameters affected the biomarker response.
In Kenya however, Were et al [100] reported that socio-
economic background, health conditions, dietary habitsEnvironmental Health 2009, 8:8 http://www.ehjournal.net/content/8/1/8
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and urban or rural living had a significant effect on lead,
cadmium, zinc and iron concentrations in the fingernails
of school children. For arsenic, Brima and co-workers
illustrated that different ethnic groups showed signifi-
cantly different concentrations of total arsenic in finger-
nails, suggestive of a different pattern of arsenic
metabolism in different ethnic groups [101].
Conclusion
For many years, blood has been seen as the ideal matrix
for HBM as it is in contact with all tissues and in equilib-
rium with organs and tissues. However, blood sampling is
an invasive procedure and suffers from ethical and practi-
cal constraints, particularly for small children or other sus-
ceptible populations. The use of non-invasively collected
matrices can be a valuable alternative to, or addition for,
invasive matrices for most contaminants discussed. Gen-
erally, there is good agreement between biomarkers meas-
ured in invasively and non-invasively collected matrices.
However, if chosen carefully, non-invasively collected
matrices can offer valuable added information on the evo-
lution of exposure (meconium, hair, finger/toenail), the
transfer of contaminants between mother and child (pla-
centa, cord blood, breast milk) or the presence of volatile
or rapidly metabolised substances (saliva, exhaled air,
urine). By far the most advantageous property of non-
invasively collected matrices is that repeated sampling,
even in susceptible populations, poses a much lower
stress on the participants and allows for a much wider
inclusion of all layers of the population.
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